Search Results - "Breining, Dorit"
-
1
Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
Published in Cell death & disease (28-01-2019)“…The mevalonate pathway has emerged as a promising target for several solid tumors. Statins are inhibitors of the 3-hydroxy-3-methylglutaryl-CoA reductase…”
Get full text
Journal Article -
2
High serum levels of periostin are associated with a poor survival in breast cancer
Published in Breast cancer research and treatment (01-04-2020)“…Purpose Periostin is a secreted extracellular matrix protein, which was originally described in osteoblasts. It supports osteoblastic differentiation and bone…”
Get full text
Journal Article -
3
Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients
Published in Journal of bone oncology (01-06-2019)“…Semaphorin 4D (Sema4D) is a glycoprotein that inhibits bone formation and has been associated with cancer progression and the occurrence of bone metastases…”
Get full text
Journal Article -
4
Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase
Published in Biochemical and biophysical research communications (28-05-2024)“…Prostate cancer is the most prevalent malignancy in men. While diagnostic and therapeutic interventions have substantially improved in recent years, disease…”
Get full text
Journal Article -
5
Small-molecule CBP/p300 histone acetyltransferase inhibition mobilizes leukocytes from the bone marrow via the endocrine stress response
Published in Immunity (Cambridge, Mass.) (13-02-2024)“…Mutations of the CBP/p300 histone acetyltransferase (HAT) domain can be linked to leukemic transformation in humans, suggestive of a checkpoint of leukocyte…”
Get more information
Journal Article